Observed arrival · 2026-09-06

Bureau483, Before the Warning Letter

bureau483.com Observed source

Editorial interest 78/100 Selection signal · not a rating of the site

Bureau483 offers FDA enforcement intelligence for consulting firms, tracking the gap between facility inspection close and warning-letter issuance.

Landing page captured for the 2026-09-06 issue.

Field notes

The product models the interval between an FDA inspection close and a subsequent warning letter, then presents the resulting opportunity as a lead signal for consulting firms. The homepage cites an 87-day average lag in the Northeast against a 124-day national median, alongside a 26% OAI-to-warning-letter conversion figure. It also advertises a dashboard and API, but the visible page does not explain the underlying data source or show the dashboard itself.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible

⊠LoginAccess appeared gated

✦PrettyNotable craft visible

●ProPolished or operationally mature

◎NicheUnusually specific use

One card from the complete issue

Paperwork for the Close-Up

294,223 arrived 1,000 judged 1000 catalogued Enter the complete issue